Global and China HER2-negative Breast Cancer Market Research Report Forecast 2017 to 2022

July 2017 | 126 pages | ID: G0764DFAE9BEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Global and China HER2-negative Breast Cancer Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the HER2-negative Breast Cancer industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This HER2-negative Breast Cancer market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global and China HER2-negative Breast Cancer Market: Regional Segment Analysis

Global
China

The Major players reported in the market include:

F. Hoffmann-La Roche
Novartis
Pfizer
AbbVie
AstraZeneca
BioMarin
Bristol-Myers Squibb
Eisai
Eli Lilly

Global and China HER2-negative Breast Cancer Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

Global and China HER2-negative Breast Cancer Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 HER2-NEGATIVE BREAST CANCER MARKET OVERVIEW

1.1 HER2-negative Breast Cancer Definition
1.2 HER2-negative Breast Cancer Classification and Application
1.3 HER2-negative Breast Cancer Industry Chain
1.4 HER2-negative Breast Cancer Industry Overview

CHAPTER 2 GLOBAL AND CHINA ECONOMIC IMPACT ON HER2-NEGATIVE BREAST CANCER INDUSTRY

2.1 Global Macroeconomic Environment Analysis
2.2 China Macroeconomic Environment Analysis

CHAPTER 3 GLOBAL HER2-NEGATIVE BREAST CANCER COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

3.1 Global HER2-negative Breast Cancer Market Competition by Manufacturers
  3.1.1 Global HER2-negative Breast Cancer Production and Market Share of Key Manufacturers (2012-2017)
  3.1.2 Global HER2-negative Breast Cancer Revenue and Share by Manufacturers (2012-2017)
3.2 Global HER2-negative Breast Cancer Production and Revenue by Type
  3.3.1 Global HER2-negative Breast Cancer Production and Market Share by Type (2012-2017)
  3.3.2 Global HER2-negative Breast Cancer Revenue and Market Share by Type (2012-2017)
3.3 Global HER2-negative Breast Cancer Production and Revenue by Application

CHAPTER 4 CHINA HER2-NEGATIVE BREAST CANCER MARKET ANALYSIS

4.1 China HER2-negative Breast Cancer Production and Revenue (2012-2017)
  4.1.1 China HER2-negative Breast Cancer Production and Growth Rate (2012-2017)
  4.1.2 China HER2-negative Breast Cancer Revenue and Growth Rate (2012-2017)
  4.1.3 China HER2-negative Breast Cancer Sales Price Trend (2012-2017)
4.2 China HER2-negative Breast Cancer Production and Market Share by Manufacturers
4.3 China HER2-negative Breast Cancer Production and Market Share by Type
4.4 China HER2-negative Breast Cancer Production and Market Share by Application

CHAPTER 5 GLOBAL HER2-NEGATIVE BREAST CANCER MANUFACTURERS ANALYSIS

5.1 F. Hoffmann-La Roche
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Product Type, Application and Specification
  5.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.1.4 Business Overview
5.2 Novartis
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 Product Type, Application and Specification
  5.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.2.4 Business Overview
5.3 Pfizer
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 Product Type, Application and Specification
  5.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.3.4 Business Overview
5.4 AbbVie
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 Product Type, Application and Specification
  5.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.4.4 Business Overview
5.5 AstraZeneca
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 Product Type, Application and Specification
  5.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.5.4 Business Overview
5.6 BioMarin
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 Product Type, Application and Specification
  5.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.6.4 Business Overview
5.7 Bristol-Myers Squibb
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 Product Type, Application and Specification
  5.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.7.4 Business Overview
5.8 Eisai
  5.8.1 Company Basic Information, Manufacturing Base and Competitors
  5.8.2 Product Type, Application and Specification
  5.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.8.4 Business Overview
5.9 Eli Lilly
  5.9.1 Company Basic Information, Manufacturing Base and Competitors
  5.9.2 Product Type, Application and Specification
  5.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.9.4 Business Overview

CHAPTER 6 HER2-NEGATIVE BREAST CANCER MANUFACTURING COST ANALYSIS

6.1 HER2-negative Breast Cancer Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of HER2-negative Breast Cancer

CHAPTER 7 MARKET EFFECT FACTORS ANALYSIS

7.1 Technology Progress/Risk
  7.1.1 Substitutes Threat
  7.1.2 Technology Progress in Related Industry
7.2 Consumer Needs/Customer Preference Change
7.3 Economic/Political Environmental Change

CHAPTER 8 GLOBAL HER2-NEGATIVE BREAST CANCER MARKET FORECAST (2017-2022)

8.1 Global HER2-negative Breast Cancer Production, Revenue Forecast (2017-2022)
8.2 Global HER2-negative Breast Cancer Production Forecast by Type (2017-2022)
8.3 Global HER2-negative Breast Cancer Consumption Forecast by Application (2017-2022)
8.4 China HER2-negative Breast Cancer Production, Consumption Forecast by Regions (2017-2022)
8.5 HER2-negative Breast Cancer Price Forecast (2017-2022)

CHAPTER 9 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of HER2-negative Breast Cancer
Figure Global Production Market Share of HER2-negative Breast Cancer by Type in 2016
Table HER2-negative Breast Cancer Consumption Market Share by Application in 2016
Table Global HER2-negative Breast Cancer Capacity of Key Manufacturers (2015 and 2016)
Table Global HER2-negative Breast Cancer Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global HER2-negative Breast Cancer Capacity of Key Manufacturers in 2015
Figure Global HER2-negative Breast Cancer Capacity of Key Manufacturers in 2016
Table Global HER2-negative Breast Cancer Production of Key Manufacturers (2015 and 2016)
Table Global HER2-negative Breast Cancer Production Share by Manufacturers (2015 and 2016)
Figure 2015 HER2-negative Breast Cancer Production Share by Manufacturers
Figure 2016 HER2-negative Breast Cancer Production Share by Manufacturers
Table Global HER2-negative Breast Cancer Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global HER2-negative Breast Cancer Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global HER2-negative Breast Cancer Revenue Share by Manufacturers
Table 2016 Global HER2-negative Breast Cancer Revenue Share by Manufacturers
Table Global Market HER2-negative Breast Cancer Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market HER2-negative Breast Cancer Average Price of Key Manufacturers in 2015
Table Manufacturers HER2-negative Breast Cancer Manufacturing Base Distribution and Sales Area
Table Manufacturers HER2-negative Breast Cancer Product Type
Figure HER2-negative Breast Cancer Market Share of Top 3 Manufacturers
Figure HER2-negative Breast Cancer Market Share of Top 5 Manufacturers
Table Global HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table China HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Global HER2-negative Breast Cancer Production by Type (2012-2017)
Table Global HER2-negative Breast Cancer Production Share by Type (2012-2017)
Figure Production Market Share of HER2-negative Breast Cancer by Type (2012-2017)
Figure 2015 Production Market Share of HER2-negative Breast Cancer by Type
Table Global HER2-negative Breast Cancer Revenue by Type (2012-2017)
Table Global HER2-negative Breast Cancer Revenue Share by Type (2012-2017)
Figure Production Revenue Share of HER2-negative Breast Cancer by Type (2012-2017)
Figure 2015 Revenue Market Share of HER2-negative Breast Cancer by Type
Table Global HER2-negative Breast Cancer Price by Type (2012-2017)
Figure Global HER2-negative Breast Cancer Production Growth by Type (2012-2017)
Table Global HER2-negative Breast Cancer Consumption by Application (2012-2017)
Table Global HER2-negative Breast Cancer Consumption Market Share by Application (2012-2017)
Figure Global HER2-negative Breast Cancer Consumption Market Share by Application in 2016
Table Global HER2-negative Breast Cancer Consumption Growth Rate by Application (2012-2017)
Figure Global HER2-negative Breast Cancer Consumption Growth Rate by Application (2012-2017)
Figure China HER2-negative Breast Cancer Production and Growth Rate (2012-2017)
Figure China HER2-negative Breast Cancer Revenue and Growth Rate (2012-2017)
Figure China HER2-negative Breast Cancer Production Price Trend (2012-2017)
Table China HER2-negative Breast Cancer Production by Manufacturers (2012-2017)
Table China HER2-negative Breast Cancer Market Share by Manufacturers (2012-2017)
Table China HER2-negative Breast Cancer Production by Type (2012-2017)
Table China HER2-negative Breast Cancer Market Share by Type (2012-2017)
Table China HER2-negative Breast Cancer Production by Application (2012-2017)
Table China HER2-negative Breast Cancer Market Share by Application (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffmann-La Roche HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche HER2-negative Breast Cancer Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis HER2-negative Breast Cancer Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer HER2-negative Breast Cancer Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AbbVie HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie HER2-negative Breast Cancer Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca HER2-negative Breast Cancer Market Share (2012-2017)
Table BioMarin Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BioMarin HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table BioMarin HER2-negative Breast Cancer Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb HER2-negative Breast Cancer Market Share (2012-2017)
Table Eisai Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eisai HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Eisai HER2-negative Breast Cancer Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly HER2-negative Breast Cancer Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of HER2-negative Breast Cancer
Figure Manufacturing Process Analysis of HER2-negative Breast Cancer
Figure HER2-negative Breast Cancer Industrial Chain Analysis
Table Raw Materials Sources of HER2-negative Breast Cancer Major Manufacturers in 2016
Table Major Buyers of HER2-negative Breast Cancer
Table Distributors/Traders List
Figure Global HER2-negative Breast Cancer Production and Growth Rate Forecast (2017-2022)
Figure Global HER2-negative Breast Cancer Revenue and Growth Rate Forecast (2017-2022)
Table Global HER2-negative Breast Cancer Production Forecast by Type (2017-2022)
Table Global HER2-negative Breast Cancer Consumption Forecast by Application (2017-2022)
Table China HER2-negative Breast Cancer Production and Consumption Forecast by Regions (2017-2022)